ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260034.1	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.040971123	Sensitive
ENSG00000260034.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.032871276	Sensitive